Cisplatin-resistant triple-negative breast cancer subtypes: multiple mechanisms of resistance

ABSTRACT: BACKGROUND: Understanding mechanisms underlying specific chemotherapeutic responses in subtypes of cancer may improve identification of treatment strategies most likely to benefit particular patients. For example, triple-negative breast cancer (TNBC) patients have variable response to the...

Descripción completa

Detalles Bibliográficos
Autores principales: Hill, David P., Harper, Akeena, Malcolm, Joan, McAndrews, Monica S., Mockus, Susan M., Patterson, Sara E., Reynolds, Timothy, Baker, Erich J., Bult, Carol J., Chesler, Elissa J., Blake, Judith A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6829976/
https://www.ncbi.nlm.nih.gov/pubmed/31684899
http://dx.doi.org/10.1186/s12885-019-6278-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6829976/
https://www.ncbi.nlm.nih.gov/pubmed/31684899
http://dx.doi.org/10.1186/s12885-019-6278-9

Ejemplares similares